Holen Sie sich die Stockscreener-App
6.81
5.55%
-0.40
Handel nachbörslich:
6.81
Schlusskurs vom Vortag:
$7.21
Offen:
$7.21
24-Stunden-Volumen:
1.91M
Relative Volume:
1.29
Marktkapitalisierung:
$697.56M
Einnahmen:
$187.64M
Nettoeinkommen (Verlust:
$-95.00M
KGV:
-7.1684
EPS:
-0.95
Netto-Cashflow:
$-69.02M
1W Leistung:
-4.35%
1M Leistung:
-0.15%
6M Leistung:
-17.75%
1J Leistung:
-52.44%
1-Tages-Spanne:
$6.80
$7.26
1-Wochen-Bereich:
$6.80
$7.27
52-Wochen-Spanne:
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Firmenname
Day One Biopharmaceuticals Inc
Sektor
Branche
Telefon
650 484-0899
Adresse
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Vergleichen Sie DAWN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
6.81 | 738.53M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-09 | Bestätigt | Needham | Buy |
| 2024-08-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-04-24 | Bestätigt | Needham | Buy |
| 2023-04-25 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-08 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-03 | Eingeleitet | Oppenheimer | Perform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Buy |
| 2022-12-01 | Eingeleitet | BofA Securities | Buy |
Alle ansehen
Day One Biopharmaceuticals Inc Aktie (DAWN) Neueste Nachrichten
Can Day One Biopharmaceuticals Inc. hit a new high this monthPortfolio Risk Summary & Community Driven Trade Alerts - newser.com
Custom watchlist performance reports with OCCIJuly 2025 Decliners & Verified Short-Term Plans - newser.com
Insider Buy: Can Day One Biopharmaceuticals Inc outperform under higher oil prices - khodrobank.com
Institutional scanner results for Day One Biopharmaceuticals Inc.Weekly Trade Review & Detailed Earnings Play Alerts - newser.com
What machine learning models say about Day One Biopharmaceuticals Inc.Fed Meeting & Weekly Momentum Picks - newser.com
Moving Averages: Is Day One Biopharmaceuticals Inc stock a good dividend stockJuly 2025 PreEarnings & AI Enhanced Execution Alerts - khodrobank.com
CEO Change: What are the future prospects of Day One Biopharmaceuticals IncTrade Performance Summary & Weekly Stock Breakout Alerts - khodrobank.com
Investor Mood: What’s the outlook for Day One Biopharmaceuticals Inc.’s sectorWeekly Market Summary & Reliable Price Action Trade Plans - khodrobank.com
Block Trades: Will Day One Biopharmaceuticals Inc stock go up in YEAROptions Play & Real-Time Sentiment Analysis - خودرو بانک
Can volume confirm reversal in Day One Biopharmaceuticals Inc.Market Activity Summary & Expert Verified Stock Movement Alerts - newser.com
Dynamic Technology Lab Private Ltd Acquires Shares of 48,457 Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Earnings Update: Can Day One Biopharmaceuticals Inc outperform under higher oil prices2025 Investor Takeaways & Short-Term Swing Trade Alerts - khodrobank.com
Real time scanner hits for Day One Biopharmaceuticals Inc. explainedPortfolio Growth Summary & Real-Time Chart Pattern Alerts - newser.com
Energy Moves: Can Day One Biopharmaceuticals Inc beat the S P 500July 2025 Spike Watch & Precise Buy Zone Identification - خودرو بانک
JonesTrading Maintains Buy Rating on Day One Biopharmaceuticals (DAWN) Following Ojemda’s FDA Approval - MSN
ETF Watch: Is Aemetis Inc. a turnaround story2025 Price Momentum & Free Expert Verified Stock Movement Alerts - خودرو بانک
Aug Ideas: Is Day One Biopharmaceuticals Inc a strong growth stockWeekly Investment Recap & Long Hold Capital Preservation Plans - خودرو بانک
Market Pulse: Can Day One Biopharmaceuticals Inc outperform under higher oil pricesJuly 2025 Intraday Action & Fast Moving Stock Trade Plans - خودرو بانک
Downgrade Watch: Is Hawkins Inc. stock a smart retirement pickWeekly Stock Recap & Stock Portfolio Risk Management - خودرو بانک
Aug Final Week: Is 908 Devices Inc. in accumulation or distribution phase2025 Fundamental Recap & Safe Entry Point Identification - خودرو بانک
Tech Rally: Is Dianthus Therapeutics Inc stock a hidden gemMarket Volume Summary & Daily Risk Controlled Trade Plans - khodrobank.com
CEO Moves: Will Day One Biopharmaceuticals Inc face regulatory challengesJuly 2025 Spike Watch & Precise Buy Zone Identification - khodrobank.com
Hedge Fund Moves: Is Day One Biopharmaceuticals Inc stock a good dividend stockJuly 2025 Trade Ideas & Smart Swing Trading Alerts - خودرو بانک
Pullback Watch: Can Day One Biopharmaceuticals Inc outperform under higher oil pricesJuly 2025 Opening Moves & Daily Profit Focused Stock Screening - khodrobank.com
Chipmakers Recap: What are Day One Biopharmaceuticals Inc.’s technical support levelsMarket Activity Report & Free Safe Entry Trade Signal Reports - خودرو بانک
Retail Surge: How is Day One Biopharmaceuticals Inc managing supply chain issuesQuarterly Performance Summary & AI Forecasted Entry and Exit Points - khodrobank.com
Published on: 2025-09-15 12:18:26 - khodrobank.com
Will earnings trigger a reversal in Day One Biopharmaceuticals Inc.Weekly Volume Report & Free Reliable Trade Execution Plans - newser.com
real time scanner hits for day one biopharmaceuticals inc. explainedEarnings Growth Summary & Verified Momentum Watchlists - newser.com
Using economic indicators to assess Day One Biopharmaceuticals Inc. potentialJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Parkman Healthcare Partners LLC Buys 42,688 Shares of Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Trexquant Investment LP Purchases 116,810 Shares of Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Ieq Capital LLC Acquires New Holdings in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Estuary Capital Management LP Has $26.38 Million Stock Holdings in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Alyeska Investment Group L.P. Boosts Stock Holdings in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Bollinger Bands Show Potential Breakout in Day One Biopharmaceuticals Inc.Bear Alert & Capital Efficiency Focused Strategies - beatles.ru
Piper Sandler Starts Coverage on Day One (DAWN) with Overweight Rating - MSN
Day One Biopharmaceuticals Inc. Recovers — But Is It SustainableJuly 2025 Macro Moves & AI Enhanced Market Trend Forecasts - beatles.ru
American Century Companies Inc. Buys Shares of 14,415 Day One Biopharmaceuticals, Inc. $DAWN - Defense World
Top 10 Stocks Under $10 That Could Triple - Insider Monkey
139,658 Shares in Day One Biopharmaceuticals, Inc. $DAWN Bought by Nuveen LLC - MarketBeat
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Held Back By Insufficient Growth Even After Shares Climb 30% - simplywall.st
Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):